| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |